SCHEMBL19784056

SCHEMBL19784056

NCc1ccc(-c2ccc(C(C=O)c3ccccc3)cc2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
AKT2 P31751 2/20 0.38
SRC P12931 1/20 0.33
TAAR1 Q96RJ0 2/20 0.33
BACE1 P56817 1/20 0.32
LOXL2 Q9Y4K0 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31
ACP3 P15309 1/20 0.31
KLKB1 P03952 1/20 0.31
PRMT5 O14744 1/20 0.31
WDR77 Q9BQA1 1/20 0.31
ROCK1 Q13464 3/20 0.31
RPS6KA5 O75582 2/20 0.31
AKT1 P31749 2/20 0.31
GSK3B P49841 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30083604 0.79 TAAR1 (0.50) CHRNB2CHRNA4SRCTAAR1LOXL2
SCHEMBL10133262 0.79 TAAR1 (0.50) CHRNB2CHRNA4SRCTAAR1LOXL2
SCHEMBL1515909 0.76 ACP3 (0.48) CHRNB2CHRNA4CA12CA1CA2
SCHEMBL13368895 0.74 ACP3 (0.47) CHRNB2CHRNA4TAAR1ACP3MAPK1
SCHEMBL193931 0.70 CYP2D6 (0.48) SRCMAPK1
SCHEMBL17680466 0.69 SYK (0.36) PRMT5WDR77
SCHEMBL19784436 0.69 CYP2E1 (0.61) CHRNB2CHRNA4LOXL2
SCHEMBL22840001 0.69 ADH1B (0.38) SRCBACE1CDK2LIPG
SCHEMBL6264168 0.68 SRC (0.41) SRCLIPG
Hydrochloric Acid SCHEMBL31716379 0.68 ALDH1A1 (0.50) TAAR1LOXL2PRMT5WDR77MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 EP disclosed
WO-2018011090-A1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2018-01-18 WO disclosed